Literature DB >> 30517764

Paradoxical Effects of Emodin on ANIT-Induced Intrahepatic Cholestasis and Herb-Induced Hepatotoxicity in Mice.

Xue Wang1, Lifeng Han2, Yajuan Bi1, Caiyu Li1, Xiumei Gao2,3, Guanwei Fan2,3, Youcai Zhang1.   

Abstract

Emodin is an active ingredient in many herbal medicines and has a broad spectrum of pharmacological activities. The current data indicate that emodin exerts its beneficial effect on alpha-naphthylisothiocyanate (ANIT)-induced intrahepatic cholestasis through its anti-oxidant and anti-inflammatory activities. Emodin has little effect on the concentrations of bile acids (BAs) in livers of ANIT-treated mice. Instead, emodin shows a potential pro-cholestatic effect by interfering with the crosstalk between AMP-activated protein kinase (AMPK) and farnesoid X receptor (Fxr) in the liver, which leads to a suppression of bile salt export pump (Bsep). Two emodin-containing herbs, namely Polygonum multiflorum (PM) and Semen cassiae (SC), markedly aggravate the intrahepatic cholestasis in ANIT-treated mice. SC interferes with the AMPK-Fxr crosstalk and suppresses Bsep in livers of mice. ANIT markedly increases the hepatic retention of emodin in SC-treated mice. The major SC constituents, in particular three anthraquinones, are able to activate AMPK in HepG2 cells and inhibit Bsep in primary mouse hepatocytes, with emodin showing the strongest activities. Together, the present study identifies a potential pro-cholestatic role of emodin in the hepatotoxicity of herbs.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AMPK; ANIT-induced cholestasis; emodin

Mesh:

Substances:

Year:  2019        PMID: 30517764     DOI: 10.1093/toxsci/kfy295

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  2 in total

1.  Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.

Authors:  Bo Li; Xin Zhao; Lei Zhang; Wen Cheng
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

Review 2.  Therapeutic Potential of Emodin for Gastrointestinal Cancers.

Authors:  Sierra J McDonald; Brandon N VanderVeen; Kandy T Velazquez; Reilly T Enos; Ciaran M Fairman; Thomas D Cardaci; Daping Fan; E Angela Murphy
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.